Literature DB >> 7272181

High unbound fraction of salicylate in plasma during intoxication.

G Alván, U Bergman, L L Gustafsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7272181      PMCID： PMC1402197          DOI： 10.1111/j.1365-2125.1981.tb01182.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  Protein binding of salicylate in uremic and normal plasma.

Authors:  O Borgå; I O Cederlöf; V A Ringberger; A Norlin
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

2.  Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man.

Authors:  G Levy; T Tsuchiya; L P Amsel
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

3.  Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.

Authors:  M Ehrnebo; S Agurell; B Jalling; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

4.  A chronic dose-ranging kinetic study of salicylate in man [proceedings].

Authors:  L J Aarons; F Bochner; M Rowland
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

5.  Errors in interpretation of data from equilibrium dialysis protein binding experiments.

Authors:  H L Behm; J G Wagner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1979-10

6.  Pharmacokinetics of salicylate elimination in man.

Authors:  G Levy
Journal:  J Pharm Sci       Date:  1965-07       Impact factor: 3.534

7.  Theoretical analysis of the binding of salicylate by human serum albumin: the relationship between free and bound drug and therapeutic levels.

Authors:  W D Wosilait
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

8.  Concentration dependent plasma protein binding of salicylate in rheumatoid patients.

Authors:  R Ekstrand; G Alvan; O Borga
Journal:  Clin Pharmacokinet       Date:  1979 Mar-Apr       Impact factor: 6.447
  8 in total
  3 in total

1.  Guidance document: management priorities in salicylate toxicity.

Authors: 
Journal:  J Med Toxicol       Date:  2015-03

2.  Rationale for monitoring free drug levels.

Authors:  R H Levy; T A Moreland
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

Review 3.  A reassessment of the treatment of salicylate poisoning.

Authors:  L Notarianni
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.